Kuano
Engineering Software · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Hauxton House Mill Scitech Park Mill Ln,...Website
www.kuano.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
2
1
1
1
About Kuano
Founded in 2020, Kuano is a software platform for rapid, cost-effective quantum modeling of enzymes. Kuano is using its platform to advance its pipeline of novel therapeutics targeting unmet medical needs, as well as in collaborative programs with leading academic and commercial partners. The company is headquartered in London, England, United Kingdom.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kuano your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kuano, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Kuano recently announced quarterly report
Funding: Get notified immidiatlly once Kuano has new funding data
Check out if Kuano is spiking on competitors!
Product Launch: Get notified when Kuano launches new products
Congratulate Masked Content for being promoted to Masked Content at Kuano
Check if Kuano has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Kuano had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Kuano
Find 2 more new buyers
Compare Similar Companies to Kuano
Compare insights from companies similar to Kuano, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kuano
<$5M
1-10
Private
<$5M
2020
N/A
Company Profile Activity
Activity Insights
Kuano is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Kuano is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Kuano.
Kuano financials insights
Gather financial insights about Kuano, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$1.4M
2023
Angel/Seed
$2.2M
Kuano Tech Stack
A closer look at the technologies used by Kuano
Kuano News & Media
AI and quantum drug discovery startup Kuano secures £1.8m
Mercia Ventures has led a £1.8m seed financing round into the Cambridge-based AI drug-finding startup Kuano.Kuano raises closes £1.8M harnessing quantum mechanics and AI for drug design
Today drug discovery company Kuano, announced the close of a £1.8 million seed funding round.The company combines quantum mechanics with AI to design the next generation of medicines, focusing on seei...Kuano.ai raises GBP1m in seed funding
Kuano.ai raises GBP1m in seed funding Submitted 08/07/2021 - 9:54am Kuano.ai, a software platform for rapid, cost effective quantum modelling of enzymes, has raised GBP1 million in seed funding from ACF Investors, o2h Ventures and a syndicate of Cambridge-based angel investors. The funding will accelerate the company’s growth as it moves further towards commercialisation. Kuano combines quantum physics, artificial intelligence (AI) and medicinal chemistry in a unique approach to transforming the
Read more news
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kuano
Sign Up For FreeTo access detailed company insights
Founded in 2020, Kuano is a software platform for rapid, cost-effective quantum modeling of enzymes. Kuano is using its platform to advance its pipeline of novel therapeutics targeting unmet medical needs, as well as in collaborative programs with leading academic and commercial partners. The company is headquartered in London, England, United King... Read More
